155 related articles for article (PubMed ID: 16173059)
1. Calcium-dependent and independent mechanisms of capsaicin receptor (TRPV1)-mediated cytokine production and cell death in human bronchial epithelial cells.
Reilly CA; Johansen ME; Lanza DL; Lee J; Lim JO; Yost GS
J Biochem Mol Toxicol; 2005; 19(4):266-75. PubMed ID: 16173059
[TBL] [Abstract][Full Text] [Related]
2. TRPV1 antagonists elevate cell surface populations of receptor protein and exacerbate TRPV1-mediated toxicities in human lung epithelial cells.
Johansen ME; Reilly CA; Yost GS
Toxicol Sci; 2006 Jan; 89(1):278-86. PubMed ID: 16120755
[TBL] [Abstract][Full Text] [Related]
3. Capsaicinoids cause inflammation and epithelial cell death through activation of vanilloid receptors.
Reilly CA; Taylor JL; Lanza DL; Carr BA; Crouch DJ; Yost GS
Toxicol Sci; 2003 May; 73(1):170-81. PubMed ID: 12721390
[TBL] [Abstract][Full Text] [Related]
4. Transient receptor potential vanilloid 1 agonists cause endoplasmic reticulum stress and cell death in human lung cells.
Thomas KC; Sabnis AS; Johansen ME; Lanza DL; Moos PJ; Yost GS; Reilly CA
J Pharmacol Exp Ther; 2007 Jun; 321(3):830-8. PubMed ID: 17332266
[TBL] [Abstract][Full Text] [Related]
5. TRPV1 mediates capsaicin-stimulated metabolic activity but not cell death or inhibition of interleukin-1β release in human THP-1 monocytes.
Kunde DA; Yingchoncharoen J; Jurković S; Geraghty DP
Toxicol Appl Pharmacol; 2018 Dec; 360():9-17. PubMed ID: 30244119
[TBL] [Abstract][Full Text] [Related]
6. Transient receptor potential vanilloid 1 receptors mediate acid-induced mucin secretion via Ca2+ influx in human airway epithelial cells.
Yu H; Li Q; Zhou X; Kolosov VP; Perelman JM
J Biochem Mol Toxicol; 2012 May; 26(5):179-86. PubMed ID: 22566028
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship of capsaicin analogs and transient receptor potential vanilloid 1-mediated human lung epithelial cell toxicity.
Thomas KC; Ethirajan M; Shahrokh K; Sun H; Lee J; Cheatham TE; Yost GS; Reilly CA
J Pharmacol Exp Ther; 2011 May; 337(2):400-10. PubMed ID: 21343315
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress-induced posttranslational modification of TRPV1 expressed in esophageal epithelial cells.
Kishimoto E; Naito Y; Handa O; Okada H; Mizushima K; Hirai Y; Nakabe N; Uchiyama K; Ishikawa T; Takagi T; Yagi N; Kokura S; Yoshida N; Yoshikawa T
Am J Physiol Gastrointest Liver Physiol; 2011 Aug; 301(2):G230-8. PubMed ID: 21636531
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptides and capsaicin stimulate the release of inflammatory cytokines in a human bronchial epithelial cell line.
Veronesi B; Carter JD; Devlin RB; Simon SA; Oortgiesen M
Neuropeptides; 1999 Dec; 33(6):447-56. PubMed ID: 10657523
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Transient Receptor Potential Vanilloid-1 (TRPV1) Variant Activation by Coal Fly Ash Particles and Associations with Altered Transient Receptor Potential Ankyrin-1 (TRPA1) Expression and Asthma.
Deering-Rice CE; Stockmann C; Romero EG; Lu Z; Shapiro D; Stone BL; Fassl B; Nkoy F; Uchida DA; Ward RM; Veranth JM; Reilly CA
J Biol Chem; 2016 Nov; 291(48):24866-24879. PubMed ID: 27758864
[TBL] [Abstract][Full Text] [Related]
11. Transient receptor potential vanilloid-1 participates in the inhibitory effect of ginsenoside Rg1 on capsaicin-induced interleukin-8 and prostaglandin E2 production in HaCaT cells.
Huang J; Ding L; Shi D; Hu JH; Zhu QG; Gao S; Qiu L
J Pharm Pharmacol; 2012 Feb; 64(2):252-8. PubMed ID: 22221101
[TBL] [Abstract][Full Text] [Related]
12. Transient receptor potential vanilloid 1 activation induces inflammatory cytokine release in corneal epithelium through MAPK signaling.
Zhang F; Yang H; Wang Z; Mergler S; Liu H; Kawakita T; Tachado SD; Pan Z; Capó-Aponte JE; Pleyer U; Koziel H; Kao WW; Reinach PS
J Cell Physiol; 2007 Dec; 213(3):730-9. PubMed ID: 17508360
[TBL] [Abstract][Full Text] [Related]
13. Particulate matter initiates inflammatory cytokine release by activation of capsaicin and acid receptors in a human bronchial epithelial cell line.
Veronesi B; Oortgiesen M; Carter JD; Devlin RB
Toxicol Appl Pharmacol; 1999 Jan; 154(1):106-15. PubMed ID: 9882597
[TBL] [Abstract][Full Text] [Related]
14. Cloning and pharmacological characterization of mouse TRPV1.
Correll CC; Phelps PT; Anthes JC; Umland S; Greenfeder S
Neurosci Lett; 2004 Nov; 370(1):55-60. PubMed ID: 15489017
[TBL] [Abstract][Full Text] [Related]
15. Activation of epidermal vanilloid receptor-1 induces release of proinflammatory mediators in human keratinocytes.
Southall MD; Li T; Gharibova LS; Pei Y; Nicol GD; Travers JB
J Pharmacol Exp Ther; 2003 Jan; 304(1):217-22. PubMed ID: 12490594
[TBL] [Abstract][Full Text] [Related]
16. Capsaicin causes protein synthesis inhibition and microtubule disassembly through TRPV1 activities both on the plasma membrane and intracellular membranes.
Han P; McDonald HA; Bianchi BR; Kouhen RE; Vos MH; Jarvis MF; Faltynek CR; Moreland RB
Biochem Pharmacol; 2007 May; 73(10):1635-45. PubMed ID: 17274957
[TBL] [Abstract][Full Text] [Related]
17. Capsaicin induces the production of IL-6 in human upper respiratory epithelial cells.
Seki N; Shirasaki H; Kikuchi M; Himi T
Life Sci; 2007 Apr; 80(17):1592-7. PubMed ID: 17306835
[TBL] [Abstract][Full Text] [Related]
18. Characterization of SB-705498, a potent and selective vanilloid receptor-1 (VR1/TRPV1) antagonist that inhibits the capsaicin-, acid-, and heat-mediated activation of the receptor.
Gunthorpe MJ; Hannan SL; Smart D; Jerman JC; Arpino S; Smith GD; Brough S; Wright J; Egerton J; Lappin SC; Holland VA; Winborn K; Thompson M; Rami HK; Randall A; Davis JB
J Pharmacol Exp Ther; 2007 Jun; 321(3):1183-92. PubMed ID: 17392405
[TBL] [Abstract][Full Text] [Related]
19. Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue.
Sanchez MG; Sanchez AM; Collado B; Malagarie-Cazenave S; Olea N; Carmena MJ; Prieto JC; Diaz-Laviada I I
Eur J Pharmacol; 2005 May; 515(1-3):20-7. PubMed ID: 15913603
[TBL] [Abstract][Full Text] [Related]
20. A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel and selective transient receptor potential type V1 receptor antagonist, blocks channel activation by vanilloids, heat, and acid.
El Kouhen R; Surowy CS; Bianchi BR; Neelands TR; McDonald HA; Niforatos W; Gomtsyan A; Lee CH; Honore P; Sullivan JP; Jarvis MF; Faltynek CR
J Pharmacol Exp Ther; 2005 Jul; 314(1):400-9. PubMed ID: 15837819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
